Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emerald: OTX-101 in Keratoconjunctivitis Sicca
NCT02688556Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Feb 2016
- Primary completion
- Nov 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in keratoconjunctivitis sicca (KCS), sponsored by Sun Pharma. Started Feb 2016; status: completed.
02
Drugs
cyclosporine
03
Conditions
keratoconjunctivitis sicca (KCS)
Beyond the preview
Go deeper on NCT02688556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02688556.